It is a pharma private limited company based in Bidar, Karnataka, India, established in 1990.
1990 | Bidar, Karnataka, India | ActiveP.R. Drugs Private Limited, a active private limited company, was established on 05 June 1990 in Bidar, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24111KA1990PTC010978. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.20 Cr and a paid-up capital of ₹8.30 M.
It upholds a compliant status. Its leadership includes Babu Rao Vedulla (Director), Kishore Babu Harsha Naga Vedulla (Director). Past directors included Prabhakar Reddy Marpadga, Raghuveer Reddy Komati Reddy, Govardhan Reddy Reddyreddy. It holds no open charges and ₹13.74 Cr settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at H. No. 19-1-2017/1 Shiv Nagar, Bidar South, Bidar, Karnataka, 585402.
U24111KA1990PTC010978
010978
05 June 1990
₹1.20 Cr
₹8.30 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into P.R. Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Babu Rao Vedulla | Director | 17 Mar 2014 | Current |
| Kishore Babu Harsha Naga Vedulla | Director | 17 Mar 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Sep 2008 | Past |
| Pramod Abcsdd | Director | 29 Sep 2006 | Past |
| Pramod Abcsdd | Director | 28 Oct 2011 | Past |
| Pramod Abcsdd | Director | 24 Aug 2015 | Past |
| Pramod Abcsdd | Director | 03 Jan 2014 | Past |
| Pramod Abcsdd | Additional Director | 16 Jul 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
P.R. Drugs Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 1332.56% decrease in profit. The company's net worth observed a substantial decline by a decrease of 26.67%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to P.R. Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹137,397,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Mar 2016 | Canara Bank | ₹3.65 Cr | Satisfied |
| 19 Nov 2012 | State Bank Of India | ₹5.30 Cr | Satisfied |
| 11 Mar 2011 | Nkgsb Co-Op. Bank Limited | ₹1.00 Cr | Satisfied |
| 11 Mar 2011 | Nkgsb Co-Op. Bank Limited | ₹1.00 Cr | Satisfied |
| 08 Mar 2011 | Nkgsb Co-Op. Bank Limited | ₹2.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with P.R. Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of P.R. Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped P.R. Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on P.R. Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.
Progress on P.R. Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore. was documented.
Progress on A charge registered on 28 Mar 2016 via Charge ID 100103106 with Canara Bank was fully satisfied on 02 Mar 2020. was documented.
The activity A charge with Canara Bank amounted to Rs. 3.65 Cr with Charge ID 100103106 was registered on 28 Mar 2016. was completed.
The activity Babu Rao Vedulla was appointed as a Director was appointed as a Director on 17 Mar 2014 & has been associated with this company since 11 years 9 months . was completed.
Progress on Kishore Babu Harsha Naga Vedulla was appointed as a Director was appointed as a Director on 17 Mar 2014 & has been associated with this company since 11 years 9 months . was documented.
The CIN of P.R. Drugs Private Limited is U24111KA1990PTC010978.
P.R. Drugs Private Limited is headquartered at H. No. 19-1-2017/1 Shiv Nagar, Bidar South, Bidar, Karnataka, 585402.
P.R. Drugs Private Limited was incorporated on 05 June 1990.
The current directors of P.R. Drugs Private Limited are
The primary industry of P.R. Drugs Private Limited is Manufacturing.
P.R. Drugs Private Limited is unlisted.
The authorized capital of P.R. Drugs Private Limited is ₹1.20 Cr, and the paid-up capital is ₹8.30 M.
The compliance status of P.R. Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX